|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.04.25 - 16:06
|
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer (Business Wire)
|
|
|
With three decades of spearheading advances in precision medicine and diagnostic technologies, King will accelerate the company's next phase of expansion.
CHICAGO--(BUSINESS WIRE)--Turing Medical, a leader in precision brain mapping and targeting technologies, announced the appointment of Kevin King, former CEO of iRhythm Technologies, Affymetrix and Thomson Reuters Healthcare, as the company's new President and Chief Executive Officer (CEO). Turing Medical is developing advanced functional connectivity MRI processing techniques with the potential to generate highly detailed, personalized circuit maps that could help in the understanding and treatment of brain disorders.
“Bringing Kevin King on as CEO marks a defining moment for Turing,” said Nico Dosenbach, co-founder of Turing Medical. “As CEO of iRhythm, Kevin built one of the most successful digital health companies of our time—changing the standard of care for millions living with heart conditions. His track record of turning bold ideas int...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
